71 related articles for article (PubMed ID: 958532)
1. Peripheral blood lymphocyte counts and survival in breast cancer.
Fodor J
Neoplasma; 1976; 23(3):311-3. PubMed ID: 958532
[TBL] [Abstract][Full Text] [Related]
2. Total peripheral lymphocyte count and T-cell percentage in patients with breast cancer.
Jain P; Khanna NN; Chatarjee S; Das SN
J Indian Med Assoc; 1988 Jun; 86(6):143-5. PubMed ID: 3266498
[No Abstract] [Full Text] [Related]
3. The predictive value of T-lymphocyte counts in breast cancer patients treated by endocrine manipulation.
Paterson AG; Grimshaw AD; Webster DJ
Eur J Surg Oncol; 1989 Apr; 15(2):131-7. PubMed ID: 2784771
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytes and breast cancer. Relationship of blood lymphocyte count to survival in breast cancer.
Holmes FF; Fields MD
J Kans Med Soc; 1971 Mar; 72(3):135-7. PubMed ID: 5545172
[No Abstract] [Full Text] [Related]
5. Nucleolar coefficient values and absolute number of uninucleolar lymphocytes in the peripheral blood of females 10-17 years after radical treatment for breast carcinoma.
Vlastiborová A; Jakoubková J
Neoplasma; 1969 Jun; 16(3):317-20. PubMed ID: 5349800
[No Abstract] [Full Text] [Related]
6. [Regional lymph nodes and mortality in breast cancer].
Spirina NV; Ivinskaia NV
Sov Med; 1989; (4):123. PubMed ID: 2788307
[No Abstract] [Full Text] [Related]
7. [Cellular immunity in breast cancer patients].
Spielmann M; Kitschke HJ; Tietje K
Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients.
Hansen S; Grabau DA; Sørensen FB; Bak M; Vach W; Rose C
Clin Cancer Res; 2000 Jan; 6(1):139-46. PubMed ID: 10656442
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer survival is associated with telomere length in peripheral blood cells.
Svenson U; Nordfjäll K; Stegmayr B; Manjer J; Nilsson P; Tavelin B; Henriksson R; Lenner P; Roos G
Cancer Res; 2008 May; 68(10):3618-23. PubMed ID: 18483243
[TBL] [Abstract][Full Text] [Related]
10. [Changes in the lymphoid tissue of the axillary lymph nodes and the T-lymphocyte count of the blood of breast cancer patients].
Lavnikova GA; Ivinskaia NV; Eremina OF
Vopr Onkol; 1983; 29(2):43-6. PubMed ID: 6601330
[No Abstract] [Full Text] [Related]
11. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer.
Blake-Mortimer JS; Sephton SE; Carlson RW; Stites D; Spiegel D
Breast J; 2004; 10(3):195-9. PubMed ID: 15125744
[TBL] [Abstract][Full Text] [Related]
13. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
14. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
[TBL] [Abstract][Full Text] [Related]
15. [Lymphocytes of the blood, regional lymph nodes and tumor tissue in breast cancer].
Bazhenov SM; Dorosevich AE; Naperstnikov VV
Vopr Onkol; 1988; 34(9):1040-8. PubMed ID: 3055674
[No Abstract] [Full Text] [Related]
16. Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer.
Olivotto IA; Chua B; Allan SJ; Speers CH; Chia S; Ragaz J
J Clin Oncol; 2003 Mar; 21(5):851-4. PubMed ID: 12610184
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features of recurrent breast cancer--factors related to prognosis].
Tominaga T; Kitamura M
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2268-74. PubMed ID: 6639088
[TBL] [Abstract][Full Text] [Related]
18. Density of lymphocytic infiltration of primary breast cancer does not affect short-term disease-free interval or survival.
Griffith CD; Ellis IO; Bell J; Burns K; Blamey RW
J R Coll Surg Edinb; 1990 Oct; 35(5):289-92. PubMed ID: 2283605
[TBL] [Abstract][Full Text] [Related]
19. [Changes of eosinophil levels in peripheral blood in the course of the combined and comprehensive treatment of patients with breast cancer].
Sen'chukova MA; Chepasov VI
Vopr Onkol; 1996; 42(2):46-51. PubMed ID: 8815633
[TBL] [Abstract][Full Text] [Related]
20. [Cancer cells in peripheral lymph and blood and their effect on the morbidity of patients with breast cancer].
Putyrskiĭ LA
Ross Med Zh; 1992; (4):39-42. PubMed ID: 1521020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
